<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id><journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group><journal-title>Frontiers in Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2296-2360</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24400279</article-id><article-id pub-id-type="pmc">3864258</article-id><article-id pub-id-type="doi">10.3389/fped.2013.00033</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pediatrics</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Congestive Heart Failure: Experimental Model</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Corno</surname><given-names>Antonio Francesco</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/67709"/></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jones</surname><given-names>Caroline B.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mondani</surname><given-names>Giuseppina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/118525"/></contrib><contrib contrib-type="author"><name><surname>Boyett</surname><given-names>Mark R.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/22663"/></contrib><contrib contrib-type="author"><name><surname>Jarvis</surname><given-names>Jonathan Charles</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/68209"/></contrib><contrib contrib-type="author"><name><surname>Hart</surname><given-names>George</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/116260"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>School of Medical Sciences, Health Campus, University Sains Malaysia</institution>, <addr-line>Kubang Kerian, Kelantan</addr-line>, <country>Malaysia</country></aff><aff id="aff2"><sup>2</sup><institution>Core Technology Facility, University of Manchester</institution>, <addr-line>Manchester</addr-line>, <country>UK</country></aff><aff id="aff3"><sup>3</sup><institution>Alder Hey Children NHS Foundation Trust</institution>, <addr-line>Liverpool</addr-line>, <country>UK</country></aff><aff id="aff4"><sup>4</sup><institution>John Moores University</institution>, <addr-line>Liverpool</addr-line>, <country>UK</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Oswin Grollmuss, Centre Chirurgical Marie Lannelongue, France</p></fn><fn fn-type="edited-by"><p>Reviewed by: Gianni Pedrizzetti, University of Trieste, Italy; Umberto Morbiducci, Politecnico di Torino, Italy; Jan Brazdil, FN Motol, Czech Republic</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Antonio Francesco Corno, School of Medical Sciences, Health Campus, University Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia e-mail: <email>tonycorno@hotmail.com</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Pediatric Cardiology, a section of the journal Frontiers in Pediatrics.</p></fn></author-notes><pub-date pub-type="epub"><day>28</day><month>10</month><year>2013</year></pub-date><pub-date pub-type="collection"><year>2013</year></pub-date><volume>1</volume><elocation-id>33</elocation-id><history><date date-type="received"><day>09</day><month>9</month><year>2013</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Corno, Cai, Jones, Mondani, Boyett, Jarvis and Hart.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Introduction:</bold> Surgically induced, combined volume and pressure overload has been used in rabbits to create a simplified and reproducible model of acute left ventricular (LV) failure.</p><p><bold>Materials and Methods:</bold> New Zealand white male rabbits (<italic>n</italic>&#x02009;=&#x02009;24, mean weight 3.1&#x02009;&#x000b1;&#x02009;0.2&#x02009;kg) were randomly assigned to either the Control group (<italic>n</italic>&#x02009;=&#x02009;10) or to the Heart Failure group (HF, <italic>n</italic>&#x02009;=&#x02009;14). Animals in the Control group underwent &#x0201c;sham&#x0201d; procedures. Animals in the HF group underwent procedures to induce LV volume overload by inducing severe aortic valve regurgitation with aortic cusp disruption and pressure overload using an occlusive silver clip positioned around the pre-renal abdominal aorta.</p><p><bold>Results:</bold> Following <italic>Procedure-1</italic> (volume overload) echocardiography confirmed severe aortic regurgitation in all animals in the HF group, with increased mean pulse pressure difference from 18&#x02009;&#x000b1;&#x02009;3 to 38&#x02009;&#x000b1;&#x02009;3&#x02009;mmHg (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001). After <italic>Procedure-2</italic> (pressure overload) all animals in the HF group showed clinical and echocardiographic signs of constriction of the abdominal aorta and echocardiography confirmed progressively declining LV function. At the end of the protocol there was a significant increase of the heart/body weight ratio in the HF group vs. Control group (4.6&#x02009;&#x000b1;&#x02009;0.2 vs. 2.9&#x02009;&#x000b1;&#x02009;0.1&#x02009;g/kg, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), and echocardiography showed in HF group significant increase of the LV end-diastolic diameter (2.15&#x02009;&#x000b1;&#x02009;0.09 vs. 1.49&#x02009;&#x000b1;&#x02009;0.03&#x02009;cm, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and reduction of the LV shortening fraction (26.3&#x02009;&#x000b1;&#x02009;3.8 vs. 41.3&#x02009;&#x000b1;&#x02009;1.6%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><p><bold>Conclusion:</bold> This experimental model: (a) consistently produces LV hypertrophy/dilatation and subsequent congestive heart failure, (b) provides new data on the time course of LV dilatation, hypertrophy and failure, (c) allows study of the progress and evolution of LV systolic and diastolic dysfunction in the presence of induced LV failure, (d) is suitable to study intervention or pharmacological administration to reduce the negative effects of acute LV failure.</p></abstract><kwd-group><kwd>congestive heart failure</kwd><kwd>experimental research</kwd><kwd>left heart failure</kwd><kwd>ventricular dilatation</kwd><kwd>ventricular hyprtrophy</kwd></kwd-group><counts><fig-count count="7"/><table-count count="1"/><equation-count count="0"/><ref-count count="43"/><page-count count="6"/><word-count count="4455"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Left ventricular (LV) dilatation and hypertrophy have been created in experimental animal models by inducing LV volume or pressure overload.</p><p>In the last two decades the induction of experimental aortic valve regurgitation has been used to induce LV volume overload (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>).</p><p>Several studies have been reported with this experimental model of volume overload induced by aortic valve regurgitation to evaluate systolic and diastolic ventricular function, the development of myocardial fibrosis and myocyte degeneration, and the effects of various medications (<xref ref-type="bibr" rid="B4">4</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>).</p><p>Left ventricular hypertrophy has been studied in other experimental studies on animals after inducing systemic reno-vascular hypertension by clipping one of the renal arteries (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>).</p><p>This experimental model of renal hypertension with renal artery clipping has been used to study variations of biochemical and humoral factors as well as changes in the aortic wall and in the myocardium (<xref ref-type="bibr" rid="B12">12</xref>&#x02013;<xref ref-type="bibr" rid="B20">20</xref>).</p><p>As an alternative method to induce LV hypertrophy, induction of proximal systemic hypertension has been obtained by narrowing the abdominal aorta with various technical procedures (<xref ref-type="bibr" rid="B21">21</xref>&#x02013;<xref ref-type="bibr" rid="B26">26</xref>).</p><p>This experimental model of proximal systemic hypertension and subsequent LV hypertrophy has allowed studies on arterial wall reactivity and remodeling, endothelial nitric oxide production, renal function, adrenergic response, myocardial oxidative stress, and macrophage migration (<xref ref-type="bibr" rid="B21">21</xref>&#x02013;<xref ref-type="bibr" rid="B33">33</xref>).</p><p>The combination of experimental volume and pressure overload of the left ventricle has been less frequently used in previous animal models, predominantly to study electrophysiology, and rhythm disturbances (<xref ref-type="bibr" rid="B34">34</xref>&#x02013;<xref ref-type="bibr" rid="B37">37</xref>).</p><p>We report the use of a model of surgically induced, combined volume, and pressure overload in rabbits.</p><p>Previous authors described a 2-stage model of heart failure in the rabbit, with sacrifice of the animals at 6&#x02009;weeks after the first operation (<xref ref-type="bibr" rid="B34">34</xref>). We have introduced changes in the protocol extending the observation period to 8&#x02009;weeks after the operation and characterizing the model using in particular echocardiography and micro-CT scanning.</p><p>We present our simplified and reproducible model, suitable for any of the following studies:
<list list-type="simple"><list-item><label>(a)</label><p>myocardial and vascular structure and ultra-structure, metabolism and function, during and after the development of left heart failure;</p></list-item><list-item><label>(b)</label><p>effects of the combined volume and pressure overload on the conduction tissues and potential development of arrhythmias;</p></list-item><list-item><label>(c)</label><p>potential prevention of myocardial and vascular remodeling due to combined volume and pressure overload;</p></list-item><list-item><label>(d)</label><p>treatment of left heart failure with any type and/or combination of interventions and/or medications.</p></list-item></list></p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2-1"><title>Experimental animal model</title><p>New Zealand white male rabbits (<italic>n</italic>&#x02009;=&#x02009;24) were arbitrarily assigned to either the Control group (<italic>n</italic>&#x02009;=&#x02009;10) or to the HF group (<italic>n</italic>&#x02009;=&#x02009;14). Animals in the Control group underwent &#x0201c;sham&#x0201d; procedures, while animals in the HF group underwent the procedures to induce LV volume overload and pressure overload. The entire protocol is summarized in Figure <xref ref-type="fig" rid="F1">1</xref>.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Experimental protocol</bold>.</p></caption><graphic xlink:href="fped-01-00033-g001"/></fig></sec><sec id="S2-2"><title>Procedure-1&#x02009;=&#x02009;volume overload</title><p>All rabbits were anesthetized with ketamine (50&#x02009;mg/kg) and maintained with 2% isofluorane, after tracheal intubation and with self-ventilation.</p><p>Color Doppler echocardiography was performed with a GE Vivid 3 ultrasound recorder using a 5-MHz transducer in all animals before the surgical procedure.</p><p>Through a longitudinal incision in the right side of the neck, the right carotid artery was dissected free, distally ligated, and proximally controlled with a tie (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>(A)</bold> Through a longitudinal incision in the right side of the neck, the right carotid artery was dissected free, and (<bold>B)</bold> distally ligated and proximally controlled with a tie.</p></caption><graphic xlink:href="fped-01-00033-g002"/></fig><p>Through a 1-mm incision on the anterior aspect of the right carotid artery, a sharp, bevel-tipped 1.22&#x02009;mm catheter was introduced into the proximal right carotid artery (Figure <xref ref-type="fig" rid="F3">3</xref>), advanced retrogradely toward the ascending aorta, and connected to a pressure transducer whose output was monitored and recorded using ACODAS (Dataq Instruments, Akron, OH, USA) (Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Through a 1-mm incision on the anterior aspect of the right carotid artery, a sharp, bevel-tipped 1.22&#x02009;mm catheter was introduced into the proximal right carotid artery and advanced retrograde toward the ascending aorta and connected to a pressure transducer, with a computer system for data recording</bold>.</p></caption><graphic xlink:href="fped-01-00033-g003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>The catheter was then connected to a pressure transducer, with a computer system for data recording</bold>.</p></caption><graphic xlink:href="fped-01-00033-g004"/></fig></sec><sec id="S2-3"><title>Control group</title><p>At this point for the animals in the Control group the catheter was removed from the right carotid artery, the proximal carotid artery was ligated, the tissues were closed in layers and the &#x0201c;sham&#x0201d; procedure terminated, with recovery of the animals from the general anesthesia.</p></sec><sec id="S2-4"><title>Heart failure group</title><p>In the animals in the Heart Failure group aortic valve regurgitation was obtained by disruption of &#x02265;2 aortic leaflets by repeatedly moving the catheter across the aortic valve into the left ventricle, with continuous pressure recording. Fluoroscopy was not used. The degree of aortic valve regurgitation obtained was judged adequate when the on-line monitored pulse pressure (difference between systolic and diastolic pressure), measured through the same catheter when positioned in the ascending aorta, increased between 80 and 100% in comparison with the pre-procedure value. The maneuver was repeated until the desired degree of aortic valve regurgitation was reached.</p><p>At this point the catheter was withdrawn, the proximal carotid artery ligated, and the tissues were closed in layers. The animals were then allowed to recover from the general anesthesia.</p><p>Color Doppler echocardiography was performed in all animals of the Heart Failure group after the surgical procedure to evaluate the presence and degree of aortic valve regurgitation, LV dimensions (end-diastolic diameter), and function (shortening fraction). Aortic valve regurgitation was defined as severe in the presence of a jet &#x0003e;65% of the annulus.</p><p>At the end of the procedure but before recovery from anesthesia the animals were also observed for clinical signs of aortic valve regurgitation (low diastolic blood pressure, loud early diastolic murmur) and in the following 3&#x02009;weeks for the appearance of clinical signs of left heart failure: respiratory distress, tachypnea, cyanosis, edema, weight loss.</p></sec><sec id="S2-5"><title>Procedure-2&#x02009;=&#x02009;pressure overload</title><p>After an interval of 3&#x02009;weeks, all animals underwent a second general anesthesia with tracheal intubation as described before.</p><p>Color Doppler echocardiography was performed in all animals before the surgical procedure.</p><p>Through a longitudinal laparotomy (Figure <xref ref-type="fig" rid="F5">5</xref>) the abdominal aorta and the renal arteries were identified, and the abdominal aorta was dissected free above the renal arteries.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Through a longitudinal laparotomy the abdominal aorta as well as the renal arteries were identified, and the abdominal aorta was dissected free above the renal arteries</bold>.</p></caption><graphic xlink:href="fped-01-00033-g005"/></fig></sec><sec id="S2-6"><title>Control group</title><p>At this point for the animals in Control group the &#x0201c;sham&#x0201d; procedure was completed with the closure of the laparotomy incision in layers, and the animals were allowed to recover from the general anesthesia.</p></sec><sec id="S2-7"><title>Heart failure group</title><p>In the Heart Failure group a pre-measured (2.44&#x02009;mm) silver clip was positioned around the pre-renal abdominal aorta and occluded, inducing severe aortic narrowing with approximately 50% reduction of the aortic diameter (Figure <xref ref-type="fig" rid="F6">6</xref>). At this point the surgical procedure was completed with the closure of the laparotomy incision in layers, and these animals too were allowed to recover from the general anesthesia.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>(A)</bold> A pre-measured (2.44&#x02009;mm) silver clip was positioned around the pre-renal abdominal aorta and <bold>(B)</bold> occluded, inducing severe aortic narrowing with 50% reduction of the aortic diameter.</p></caption><graphic xlink:href="fped-01-00033-g006"/></fig><p>Color Doppler echocardiography was performed in all animals of the Heart Failure group after the surgical procedure to evaluate the degree of stenosis created on the abdominal aorta.</p><p>At the end of the procedure the animals were observed for clinical signs of abdominal aorta coarctation (increased non-invasive diastolic pressure in the upper limbs, discrepancy between upper and lower limbs pulsatility, systolic murmur) and in the following 5&#x02009;weeks for the appearance or modification of clinical signs of left heart failure: respiratory distress, tachypnea, cyanosis, edema, weight loss.</p></sec><sec id="S2-8"><title>Follow-up</title><p>In addition to the echocardiography evaluation performed before each procedure in all animals, Control and HF groups, LV size (end-diastolic diameter), and function (shortening fraction) was monitored with serial echocardiography performed after each procedure and at weekly intervals in the HF group. Five weeks following Procedure-2, after the final echocardiography evaluation, the animals were weighted, and the weight compared with the initial body weight, terminated by anesthetic overdose and the hearts were excised, weighed and sent for morphological study. Some hearts from each group were scanned by micro-CT with iodine contrast enhancement by the method previously described (<xref ref-type="bibr" rid="B38">38</xref>).</p><p>All procedures were carried out under the UK Home Office regulations (Animals Scientific Procedures, Act 1986).</p><p>Student&#x02019;s <italic>t</italic> test has been used to compare the results obtained in the two groups.</p></sec></sec><sec id="S3"><title>Results</title><p>Following <italic>Procedure-1</italic> (volume overload), while no animal in Control Group presented aortic regurgitation on evaluation by color Doppler echocardiography, all animals in the HF group developed severe aortic valve regurgitation confirmed on echocardiography by the presence of a broad jet of aortic regurgitation (nearing the aortic annulus size), with also diastolic flow reversal in the descending aorta. In the animals of the HF group an increased mean pulse pressure difference from 18&#x02009;&#x000b1;&#x02009;3 to 38&#x02009;&#x000b1;&#x02009;3&#x02009;mmHg (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) was recorded.</p><p>After <italic>Procedure-2</italic> (pressure overload) in all animals in the HF group there were signs of abdominal aortic constriction: palpable thrill and audible bruit.</p><p>In the HF group one animal was terminated before the end of the protocol because of severe clinical deterioration, three animals developed pericardial effusions and three developed ascites.</p><sec id="S3-9"><title>Morphology</title><p>The mean heart/body weight ratio was higher in the HF group than in the Control group (4.6&#x02009;&#x000b1;&#x02009;0.2 vs. 2.9&#x02009;&#x000b1;&#x02009;0.1&#x02009;g/kg, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05), notwithstanding a significant increase in the mean body weight from the beginning of the protocol in both groups, to 3.8&#x02009;kg in the HF group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) and 3.7&#x02009;kg in the Control group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>Figure <xref ref-type="fig" rid="F7">7</xref> shows representative micro-CT images of an aortic valve from the control group and from the HF group. The control valve shows leaflets that contain sufficient tissue for occlusion. The aortic valve from the HF group shows retraction of leaflet material toward the annulus and disruption of the leaflet structure 12&#x02009;weeks after the catheter intervention.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>Micro-CT images of an aortic valve from the control group (A) and from the HF group (B)</bold>. The control valve shows leaflets with sufficient tissue for occlusion. The aortic valve from the HF group shows retraction of the leaflets toward the annulus with disruption of the leaflets.</p></caption><graphic xlink:href="fped-01-00033-g007"/></fig></sec><sec id="S3-10"><title>Function</title><p>Table <xref ref-type="table" rid="T1">1</xref> shows the results of the echocardiographic functional evaluation of the LV size and function performed at the end of the protocol, with significant difference (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) between the Control Group and the HF group.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Echocardiographic evaluation at the end of the protocol</bold>.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">LV end-diastolic diameter</td><td align="left" rowspan="1" colspan="1">1.49&#x02009;&#x000b1;&#x02009;0.03&#x02009;cm</td><td align="left" rowspan="1" colspan="1">2.15&#x02009;&#x000b1;&#x02009;0.09&#x02009;cm</td><td align="left" rowspan="1" colspan="1"><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">LV shortening fraction</td><td align="left" rowspan="1" colspan="1">41.3&#x02009;&#x000b1;&#x02009;1.6%</td><td align="left" rowspan="1" colspan="1">26.3&#x02009;&#x000b1;&#x02009;3.8%</td><td align="left" rowspan="1" colspan="1"><italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table></table-wrap><p>The results of the other echocardiography observations, as well as the results of histology studies on the LV morphology and the conduction tissue, will be the subject of separate reports.</p></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>Pressure and/or volume overload in the systemic circulation characterize the pathophysiology of several congenital and acquired cardiovascular diseases.</p><p>The consequences are LV dilatation and/or hypertrophy, with ventricular remodeling and systolic and/or diastolic dysfunction due to the structural, metabolic, and functional changes in the myocardium, as well as systemic arterial remodeling, with biochemical and humoral derangements affecting the systemic circulation.</p><p>The currently available knowledge of LV failure is derived from scattered evidence coming from experimental studies reported in the literature (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B37">37</xref>) as well as from the information provided by clinical observations (<xref ref-type="bibr" rid="B39">39</xref>&#x02013;<xref ref-type="bibr" rid="B43">43</xref>).</p><p>There are still unanswered questions concerning the changes induced by the acute LV failure on the systolic and diastolic ventricular function, on the subsequent interaction between the two, and particularly on the effects of the time frame on the evolution and degree of the progress of the ventricular dysfunction.</p><p>This experimental model has the advantages of being reproducible, of inducing acute LV volume overload followed at fixed interval by induction of pressure overload, and is available to study the time course of LV dilatation, hypertrophy, and acute LV failure.</p><p>The documented increase of the mean heart/body weight ratio higher in the HF group than in the Control group (4.6&#x02009;&#x000b1;&#x02009;0.2 vs. 2.9&#x02009;&#x000b1;&#x02009;0.1&#x02009;g/kg) with significant difference (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) confirmed that the combined volume and pressure overloaded determined a substantial ventricular hypertrophy and dilatation.</p><p>The significant increase of the LV size and the impairment of the LV function (Table <xref ref-type="table" rid="T1">1</xref>) proved the validity of this experimental method in creating a congestive LV failure.</p><p>In addition to the potential capability to increase the knowledge currently available on acute LV failure, our experimental model, being reproducible, allows an unlimited series of potential studies to monitor the evolution of LV failure, with the subsequent systolic and diastolic dysfunction, as well as the effects of any type of treatment, from interventional management to pharmacological administration.</p><p>Studies using this experimental model may be potentially applicable to the pediatric practice in view of the correspondence in body weight and heart size of the animals with neonates, and given similarities in the echocardiographic profile in certain types of heart failure in pediatric patients determined by severe volume and pressure overload of the left ventricle, such as the presence of an intra-cardiac left-to-right shunt associated to an obstruction in the systemic circulation (aortic coarctation with or without hypoplastic aortic arch).</p><p>Of course the realization of this experimental model requires the facilities and organization of an animal laboratory equipped with personnel and tools allowing chronic studies, and the financial and administrative support required by such this type of investigation.</p></sec><sec id="S5"><title>Conclusion</title><sec id="S5-11"><title>This experimental model</title><list list-type="simple"><list-item><label>(a)</label><p>Consistently produces LV hypertrophy/dilatation and subsequent LV failure.</p></list-item><list-item><label>(b)</label><p>Provides new data on time course of LV dilatation, hypertrophy, and failure.</p></list-item><list-item><label>(c)</label><p>Facilitates study of the progress and evolution of LV systolic and diastolic dysfunction in the presence of induced LV failure.</p></list-item><list-item><label>(d)</label><p>Is suitable to study any type of intervention or pharmacological administration to reduce the negative effects of acute LV failure.</p></list-item></list></sec></sec><sec id="S6"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We acknowledge the very qualified technical assistance received from Robert B. T. Galvin, theater superintendent, Rob C. Hutcheon, research associate, and Christine Stalker, animal technician, during the entire duration of the experimental protocol, including preparation, surgery, and post-procedures follow-up. We would like to acknowledge The British Heart Foundation and a grant to Prof. Jonathan Jarvis from the Alder Hey Childrens&#x02019; Charity. Prof. George Hart held the David A. Price Evans Chair of Medicine at the University of Liverpool. We are also grateful to Dr. A. Bartscheer and Mr. C. N. W. Belterman for their advice.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magid</surname><given-names>NM</given-names></name><name><surname>Wallerson</surname><given-names>DC</given-names></name><name><surname>Borer</surname><given-names>JS</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Young</surname><given-names>MS</given-names></name><name><surname>Devereux</surname><given-names>RB</given-names></name><etal/></person-group>
<article-title>Left ventricular diastolic and systolic performance during chronic experimental aortic regurgitation</article-title>. <source>Am J Physiol</source> (<year>1992</year>) <volume>263</volume>:<fpage>H226</fpage>&#x02013;<lpage>33</lpage><pub-id pub-id-type="pmid">1386193</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magid</surname><given-names>NM</given-names></name><name><surname>Opio</surname><given-names>G</given-names></name><name><surname>Wallerson</surname><given-names>DC</given-names></name><name><surname>Young</surname><given-names>MS</given-names></name><name><surname>Borer</surname><given-names>JS</given-names></name></person-group>
<article-title>Heart failure due to chronic experimental aortic regurgitation</article-title>. <source>Am J Physiol</source> (<year>1994</year>) <volume>267</volume>:<fpage>H556</fpage>&#x02013;<lpage>62</lpage><pub-id pub-id-type="pmid">8067410</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsenault</surname><given-names>M</given-names></name><name><surname>Plante</surname><given-names>E</given-names></name><name><surname>Drolet</surname><given-names>MC</given-names></name><name><surname>Couet</surname><given-names>J</given-names></name></person-group>
<article-title>Experimental aortic regurgitation in rats under echocardiographic guidance</article-title>. <source>J Heart Valve Dis</source> (<year>2002</year>) <volume>11</volume>:<fpage>128</fpage>&#x02013;<lpage>34</lpage><pub-id pub-id-type="pmid">11843498</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldfine</surname><given-names>SM</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>M</given-names></name><name><surname>Magid</surname><given-names>NM</given-names></name><name><surname>Liu</surname><given-names>SK</given-names></name><name><surname>Borer</surname><given-names>JS</given-names></name></person-group>
<article-title>Myocardial collagen in cardiac hypertrophy resulting fron chronic aortic regurgitation</article-title>. <source>Am J Ther</source> (<year>1998</year>) <volume>5</volume>:<fpage>139</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="doi">10.1097/00045391-199805000-00003</pub-id><pub-id pub-id-type="pmid">10099051</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SK</given-names></name><name><surname>Magid</surname><given-names>NM</given-names></name><name><surname>Fox</surname><given-names>PR</given-names></name><name><surname>Goldfine</surname><given-names>SM</given-names></name><name><surname>Borer</surname><given-names>JS</given-names></name></person-group>
<article-title>Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation</article-title>. <source>Cardiology</source> (<year>1998</year>) <volume>90</volume>:<fpage>101</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1159/000006827</pub-id><pub-id pub-id-type="pmid">9778546</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Zanzonico</surname><given-names>P</given-names></name><name><surname>Goldfine</surname><given-names>SM</given-names></name><name><surname>Hardoff</surname><given-names>R</given-names></name><name><surname>Magid</surname><given-names>NM</given-names></name><name><surname>Gentile</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Antimyosin antibody imaging in experimental aortic regurgitation</article-title>. <source>J Nucl Cardiol</source> (<year>1997</year>) <volume>4</volume>:<fpage>25</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="doi">10.1016/S1071-3581(97)90046-5</pub-id><pub-id pub-id-type="pmid">9138836</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>E</given-names></name><name><surname>Lachance</surname><given-names>D</given-names></name><name><surname>Gaudreau</surname><given-names>M</given-names></name><name><surname>Drolet</surname><given-names>MC</given-names></name><name><surname>Roussel</surname><given-names>E</given-names></name><name><surname>Arsenault</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Effectiveness of beta-blockade in experimental chronic aortic regurgitation</article-title>. <source>Circulation</source> (<year>2004</year>) <volume>110</volume>:<fpage>1477</fpage>&#x02013;<lpage>83</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000141733.55236.9D</pub-id><pub-id pub-id-type="pmid">15353507</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plante</surname><given-names>E</given-names></name><name><surname>Lachance</surname><given-names>D</given-names></name><name><surname>Champetier</surname><given-names>S</given-names></name><name><surname>Drolet</surname><given-names>MC</given-names></name><name><surname>Roussel</surname><given-names>E</given-names></name><name><surname>Arsenault</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Benefits of long-term beta-blockade in experimental chronic aortic regurgitation</article-title>. <source>Am J Physiol</source> (<year>2008</year>) <volume>294</volume>:<fpage>H1888</fpage>&#x02013;<lpage>95</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01286.2007</pub-id><pub-id pub-id-type="pmid">18296565</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zendaoui</surname><given-names>A</given-names></name><name><surname>Lachance</surname><given-names>D</given-names></name><name><surname>Roussel</surname><given-names>E</given-names></name><name><surname>Couet</surname><given-names>J</given-names></name><name><surname>Arsenault</surname><given-names>M</given-names></name></person-group>
<article-title>Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation</article-title>. <source>J Heart Valve Dis</source> (<year>2012</year>) <volume>21</volume>:<fpage>478</fpage>&#x02013;<lpage>86</lpage><pub-id pub-id-type="pmid">22953675</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesel</surname><given-names>P</given-names></name><name><surname>Mazzolai</surname><given-names>L</given-names></name><name><surname>Nussberger</surname><given-names>J</given-names></name><name><surname>Pedrazzini</surname><given-names>T</given-names></name></person-group>
<article-title>Two-kidney, one clip and one-kindey, one clip hypertension in mice</article-title>. <source>Hypertension</source> (<year>1997</year>) <volume>29</volume>:<fpage>1025</fpage>&#x02013;<lpage>30</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.29.4.1025</pub-id><pub-id pub-id-type="pmid">9095094</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chelko</surname><given-names>SP</given-names></name><name><surname>Schmiedt</surname><given-names>CW</given-names></name><name><surname>Lewis</surname><given-names>TH</given-names></name><name><surname>Lewis</surname><given-names>SJ</given-names></name><name><surname>Robertson</surname><given-names>TP</given-names></name></person-group>
<article-title>A novel vascular clip design for the reliable induction of 2-kindney, 1-clip hypertension in the rat</article-title>. <source>J Appl Physiol</source> (<year>2012</year>) <volume>112</volume>:<fpage>362</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01015.2011</pub-id><pub-id pub-id-type="pmid">22074718</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Gillespie</surname><given-names>DG</given-names></name><name><surname>Overback</surname><given-names>HW</given-names></name></person-group>
<article-title>Humoral factors trophic for vascular smooth muscle during the development of hypertension in rats</article-title>. <source>Proc Soc Exp Biol Med</source> (<year>1995</year>) <volume>209</volume>:<fpage>32</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.3181/00379727-209-43874</pub-id><pub-id pub-id-type="pmid">7724614</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haefliger</surname><given-names>JA</given-names></name><name><surname>Castillo</surname><given-names>E</given-names></name><name><surname>Waeber</surname><given-names>G</given-names></name><name><surname>Aubert</surname><given-names>JF</given-names></name><name><surname>Nicod</surname><given-names>P</given-names></name><name><surname>Waeber</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Hypertension differentially affects the expression of the gap junction protein connexin43 in cardiac myocytes and aortic smooth muscle cells</article-title>. <source>Adv Exp Med Biol</source> (<year>1997</year>) <volume>432</volume>:<fpage>71</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="doi">10.1007/978-1-4615-5385-4_8</pub-id><pub-id pub-id-type="pmid">9433513</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>D</given-names></name><name><surname>Takai</surname><given-names>S</given-names></name><name><surname>Shiota</surname><given-names>N</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group>
<article-title>Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters</article-title>. <source>J Hypertens</source> (<year>1998</year>) <volume>16</volume>:<fpage>657</fpage>&#x02013;<lpage>64</lpage><pub-id pub-id-type="doi">10.1097/00004872-199816050-00013</pub-id><pub-id pub-id-type="pmid">9797177</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haefliger</surname><given-names>JA</given-names></name><name><surname>Meda</surname><given-names>P</given-names></name></person-group>
<article-title>Chronic hypertension alters the expression of Cx43 in cardiovascular muscle cells</article-title>. <source>Braz J Med Biol Res</source> (<year>2000</year>) <volume>33</volume>:<fpage>431</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2000000400009</pub-id><pub-id pub-id-type="pmid">10775308</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artigues-Varin</surname><given-names>C</given-names></name><name><surname>Richard</surname><given-names>V</given-names></name><name><surname>Renet</surname><given-names>S</given-names></name><name><surname>Henry</surname><given-names>JP</given-names></name><name><surname>Thuillez</surname><given-names>C</given-names></name></person-group>
<article-title>Lack of impairment of nitric oxide-mediated responses in a rat model of high-renin hypertension</article-title>. <source>Clin Exp Pharmacol Physiol</source> (<year>2002</year>) <volume>29</volume>:<fpage>26</fpage>&#x02013;<lpage>31</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1681.2002.03599.x</pub-id><pub-id pub-id-type="pmid">11906458</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>DH</given-names></name><name><surname>Mackenzie</surname><given-names>L</given-names></name><name><surname>Rajendram</surname><given-names>A</given-names></name><name><surname>Psaltis</surname><given-names>PJ</given-names></name><name><surname>Kelly</surname><given-names>DR</given-names></name><name><surname>Spyropoulos</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Characterization of cardiac remodeling in a large animal &#x0201c;one-kidney, one-clip&#x0201d; hypertensive model</article-title>. <source>Blood Press</source> (<year>2010</year>) <volume>19</volume>:<fpage>119</fpage>&#x02013;<lpage>25</lpage><pub-id pub-id-type="doi">10.3109/08037050903576767</pub-id><pub-id pub-id-type="pmid">20367547</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>PK</given-names></name><name><surname>Vyawahare</surname><given-names>NS</given-names></name><name><surname>Ladhha</surname><given-names>A</given-names></name></person-group>
<article-title>Preclinical screening models for hypertension in rodents: a review</article-title>. <source>Pharmacologyonline</source> (<year>2010</year>) <volume>3</volume>:<fpage>458</fpage>&#x02013;<lpage>72</lpage></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>JN</given-names></name><name><surname>Lasko</surname><given-names>VM</given-names></name><name><surname>Nieman</surname><given-names>ML</given-names></name><name><surname>Damhoff</surname><given-names>T</given-names></name><name><surname>Prasad</surname><given-names>V</given-names></name><name><surname>Beierwaltes</surname><given-names>WH</given-names></name><etal/></person-group>
<article-title>Renovascular hypertension using a modified two-kidney, one-clip approach in mice is not dependent on the alpha1 or alpha2 Na-K-ATPase ouabain-binding site</article-title>. <source>Am J Physiol Renal Physiol</source> (<year>2011</year>) <volume>301</volume>:<fpage>F615</fpage>&#x02013;<lpage>21</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00158.2011</pub-id><pub-id pub-id-type="pmid">21632957</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sporkova</surname><given-names>A</given-names></name><name><surname>Kopkan</surname><given-names>L</given-names></name><name><surname>Varcabova</surname><given-names>S</given-names></name><name><surname>Huskova</surname><given-names>Z</given-names></name><name><surname>Hwang</surname><given-names>SH</given-names></name><name><surname>Hammock</surname><given-names>BD</given-names></name><etal/></person-group>
<article-title>Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source> (<year>2011</year>) <volume>300</volume>:<fpage>R1468</fpage>&#x02013;<lpage>75</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00215.2010</pub-id><pub-id pub-id-type="pmid">21411763</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bevan</surname><given-names>JA</given-names></name><name><surname>Bevan</surname><given-names>RD</given-names></name><name><surname>Chang</surname><given-names>PC</given-names></name><name><surname>Pegram</surname><given-names>BL</given-names></name><name><surname>Purdy</surname><given-names>RE</given-names></name><name><surname>Su</surname><given-names>C</given-names></name></person-group>
<article-title>Analysis of changes in reactivity of rabbit arteries and veins two weeks after induction of hypertension by coarctation of the abdominal aorta</article-title>. <source>Circ Res</source> (<year>1975</year>) <volume>37</volume>:<fpage>183</fpage>&#x02013;<lpage>90</lpage><pub-id pub-id-type="doi">10.1161/01.RES.37.2.183</pub-id><pub-id pub-id-type="pmid">1149192</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meacham</surname><given-names>PW</given-names></name><name><surname>Dean</surname><given-names>RH</given-names></name><name><surname>Lawson</surname><given-names>JW</given-names></name><name><surname>Petracek</surname><given-names>MR</given-names></name><name><surname>Burnham</surname><given-names>SJ</given-names></name><name><surname>Hollifield</surname><given-names>JW</given-names></name><etal/></person-group>
<article-title>Study of the renal pressor system in experimental coarctation of the abdominal aorta</article-title>. <source>Am Surg</source> (<year>1977</year>) <volume>43</volume>:<fpage>771</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="pmid">596720</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osborne-Pellegrin</surname><given-names>MJ</given-names></name><name><surname>Coutard</surname><given-names>M</given-names></name><name><surname>Poitevin</surname><given-names>P</given-names></name><name><surname>Michel</surname><given-names>JB</given-names></name><name><surname>Levy</surname><given-names>BI</given-names></name></person-group>
<article-title>Induction of aneurysm in the rat by a stenosing cotton ligature around the inter-renal aorta</article-title>. <source>Int J Exp Pathol</source> (<year>1994</year>) <volume>75</volume>:<fpage>179</fpage>&#x02013;<lpage>90</lpage><pub-id pub-id-type="pmid">8086315</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>CO</given-names></name><name><surname>Duarte</surname><given-names>GP</given-names></name><name><surname>Lahlou</surname><given-names>S</given-names></name></person-group>
<article-title>Alpha-adrenergic responsiveness in rat isolated perfused heart after abdominal aortic coarctation</article-title>. <source>J Pharm Pharmacol</source> (<year>2002</year>) <volume>54</volume>:<fpage>139</fpage>&#x02013;<lpage>46</lpage><pub-id pub-id-type="doi">10.1211/0022357021771850</pub-id><pub-id pub-id-type="pmid">11829125</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorzalczany</surname><given-names>SB</given-names></name><name><surname>Opezzo</surname><given-names>JA</given-names></name><name><surname>del Carmen Garcia</surname><given-names>M</given-names></name><name><surname>Taira</surname><given-names>CA</given-names></name></person-group>
<article-title>Effects of clonidine on the experimental hypertension by abdominal aortic coarctation in rats</article-title>. <source>Pharmacol Res</source> (<year>2003</year>) <volume>48</volume>:<fpage>17</fpage>&#x02013;<lpage>24</lpage><pub-id pub-id-type="pmid">12770510</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fossum</surname><given-names>TW</given-names></name><name><surname>Baltzer</surname><given-names>WI</given-names></name><name><surname>Miller</surname><given-names>MW</given-names></name><name><surname>Aguirre</surname><given-names>M</given-names></name><name><surname>Whitlock</surname><given-names>D</given-names></name><name><surname>Solter</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>A novel aortic coarctation model for studying hypertension in pig</article-title>. <source>J Invest Surg</source> (<year>2003</year>) <volume>16</volume>:<fpage>35</fpage>&#x02013;<lpage>44</lpage><pub-id pub-id-type="doi">10.1080/08941930390153032</pub-id><pub-id pub-id-type="pmid">12554338</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polizio</surname><given-names>AH</given-names></name><name><surname>Gorzalcany</surname><given-names>SB</given-names></name><name><surname>Taira</surname><given-names>C</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>C</given-names></name></person-group>
<article-title>Aortic coarctation induces oxidative stress in rat tissues</article-title>. <source>Life Sci</source> (<year>2006</year>) <volume>79</volume>:<fpage>596</fpage>&#x02013;<lpage>600</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2006.02.004</pub-id><pub-id pub-id-type="pmid">16507310</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Popovic</surname><given-names>N</given-names></name><name><surname>Bridenbaugh</surname><given-names>EA</given-names></name><name><surname>Neiger</surname><given-names>JD</given-names></name><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Vannucci</surname><given-names>M</given-names></name><name><surname>Mo</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Transforming growth factor-&#x000df;signaling in hypertensive remodeling of porcine aorta</article-title>. <source>Am J Physiol</source> (<year>2009</year>) <volume>297</volume>:<fpage>H2044</fpage>&#x02013;<lpage>53</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01015.2008</pub-id><pub-id pub-id-type="pmid">19717726</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervantes-P&#x000e9;rez</surname><given-names>LG</given-names></name><name><surname>Ibarra-Lara</surname><given-names>ML</given-names></name><name><surname>Rubio</surname><given-names>ME</given-names></name><name><surname>Escalante</surname><given-names>B</given-names></name><name><surname>P&#x000e9;rez-Severiano</surname><given-names>F</given-names></name><name><surname>Soria-Castro</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Effect of clofibrate on vascular reactivity in a model of high blood pressure secondary to aortic coarctation</article-title>. <source>Pharmacol Rep</source> (<year>2010</year>) <volume>62</volume>:<fpage>874</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="pmid">21098870</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>ZW</given-names></name><name><surname>Li</surname><given-names>DJ</given-names></name><name><surname>Zhang</surname><given-names>SH</given-names></name><name><surname>Su</surname><given-names>DF</given-names></name><name><surname>Xie</surname><given-names>HH</given-names></name><etal/></person-group>
<article-title>A potential role of alpha-7 nicotinic acetylcholine receptor in cardiac angiogenesis in a pressure-overloaded rat model</article-title>. <source>J Pharmacol Sci</source> (<year>2010</year>) <volume>114</volume>:<fpage>311</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1254/jphs.09335FP</pub-id><pub-id pub-id-type="pmid">21099147</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Islas</surname><given-names>I</given-names></name><name><surname>Lopez-Sanchez</surname><given-names>P</given-names></name><name><surname>Ibarra</surname><given-names>M</given-names></name><name><surname>Gallardo-Ortiz</surname><given-names>IA</given-names></name><name><surname>Terron</surname><given-names>JA</given-names></name></person-group>
<article-title>Effect of inter-renal aortic coarctation-induced hypertension on function and expression of vascular alpha(1A)- and alpha(1D)-adrenoceptors</article-title>. <source>Can J Physiol Pharmacol</source> (<year>2012</year>) <volume>90</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage><pub-id pub-id-type="doi">10.1139/y11-099</pub-id><pub-id pub-id-type="pmid">22149309</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>K</given-names></name><name><surname>Kenessey</surname><given-names>A</given-names></name><name><surname>Ojamaa</surname><given-names>K</given-names></name></person-group>
<article-title>Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy</article-title>. <source>Am J Physiol</source> (<year>2013</year>) <volume>304</volume>:<fpage>H282</fpage>&#x02013;<lpage>93</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00595.2012</pub-id><pub-id pub-id-type="pmid">23144312</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>PY</given-names></name><name><surname>Wu</surname><given-names>YT</given-names></name><name><surname>Shih</surname><given-names>YH</given-names></name><name><surname>Sampilvanjil</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>LR</given-names></name><name><surname>Yang</surname><given-names>YJ</given-names></name><etal/></person-group>
<article-title>Coarctation-induced degenerative abdominal aortic aneurysm in a porcine model</article-title>. <source>J Vasc Surg</source> (<year>2013</year>) <volume>57</volume>:<fpage>806</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2012.08.104</pub-id><pub-id pub-id-type="pmid">23294504</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bril</surname><given-names>A</given-names></name><name><surname>Forest</surname><given-names>MC</given-names></name><name><surname>Gout</surname><given-names>B</given-names></name></person-group>
<article-title>Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure</article-title>. <source>Am J Physiol</source> (<year>1991</year>) <volume>261</volume>:<fpage>H301</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="pmid">1877658</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vermeulen</surname><given-names>JT</given-names></name><name><surname>McGuire</surname><given-names>MA</given-names></name><name><surname>Opthof</surname><given-names>T</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name><name><surname>De Bakker</surname><given-names>JM</given-names></name><name><surname>Kl&#x000f6;pping</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts</article-title>. <source>Cardiovasc Res</source> (<year>1994</year>) <volume>28</volume>:<fpage>1547</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type="doi">10.1093/cvr/28.10.1547</pub-id><pub-id pub-id-type="pmid">8001044</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opthof</surname><given-names>T</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name><name><surname>Rademaker</surname><given-names>HM</given-names></name><name><surname>Vermeulen</surname><given-names>JT</given-names></name><name><surname>Wilms-Schopman</surname><given-names>FJ</given-names></name><name><surname>Janse</surname><given-names>MJ</given-names></name></person-group>
<article-title>Changes in sinus node function in a rabbit model of heart failure with ventricular arrhythmias and sudden death</article-title>. <source>Circulation</source> (<year>2000</year>) <volume>101</volume>:<fpage>2975</fpage>&#x02013;<lpage>80</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.101.25.2975</pub-id><pub-id pub-id-type="pmid">10869272</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baartscheer</surname><given-names>A</given-names></name><name><surname>Schumacher</surname><given-names>CA</given-names></name><name><surname>Belterman</surname><given-names>CNW</given-names></name><name><surname>Coronel</surname><given-names>R</given-names></name><name><surname>Fiolet</surname><given-names>JWT</given-names></name></person-group>
<article-title>Chronic inhibition of Na<sup>+</sup>/H<sup>+</sup>-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure</article-title>. <source>Cardiovasc Res</source> (<year>2005</year>) <volume>65</volume>:<fpage>83</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2004.09.024</pub-id><pub-id pub-id-type="pmid">15621036</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname><given-names>RS</given-names></name><name><surname>Boyett</surname><given-names>MR</given-names></name><name><surname>Hart</surname><given-names>G</given-names></name><name><surname>Nikolaidou</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Corno</surname><given-names>AF</given-names></name><etal/></person-group>
<article-title>Contrast enhanced micro-computed tomography resolves the 3-Dimensional morphology of the cardiac conduction system in mammalian hearts</article-title>. <source>PLoS ONE</source> (<year>2012</year>) <volume>7</volume>:<fpage>e35299</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0035299</pub-id><pub-id pub-id-type="pmid">22509404</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>YW</given-names></name><name><surname>Fonarow</surname><given-names>GC</given-names></name><name><surname>Mi</surname><given-names>X</given-names></name><name><surname>Peacock</surname><given-names>WF</given-names><suffix>IV</suffix></name><name><surname>Mills</surname><given-names>RM</given-names></name><name><surname>Curtis</surname><given-names>LH</given-names></name><etal/></person-group>
<article-title>Early intravenous heart failure therapy and outcomes among older patients hospitalized for acute decompensated heart failure: findings from the acute decompensated heart failure registry emergency module (ADHERE-EM)</article-title>. <source>Am Heart J</source> (<year>2013</year>) <volume>166</volume>:<fpage>349</fpage>&#x02013;<lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2013.05.014</pub-id><pub-id pub-id-type="pmid">23895819</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braunwald</surname><given-names>E</given-names></name></person-group>
<article-title>Heart failure: an update</article-title>. <source>Clin Pharmacol Ther</source> (<year>2013</year>) <volume>94</volume>:<fpage>430</fpage>&#x02013;<lpage>2</lpage><pub-id pub-id-type="doi">10.1038/clpt.2013.149</pub-id><pub-id pub-id-type="pmid">24048236</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selby</surname><given-names>VN</given-names></name><name><surname>Teerlink</surname><given-names>JR</given-names></name></person-group>
<article-title>What&#x02019;s new in the treatment of acute heart failure?</article-title>
<source>Curr Cardiol Rep</source> (<year>2013</year>) <volume>15</volume>:<fpage>393</fpage><pub-id pub-id-type="doi">10.1007/s11886-013-0393-z</pub-id><pub-id pub-id-type="pmid">23881577</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishu</surname><given-names>K</given-names></name><name><surname>Redfield</surname><given-names>MM</given-names></name></person-group>
<article-title>Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy</article-title>. <source>Curr Heart Fail Rep</source> (<year>2013</year>) <volume>10</volume>:<fpage>190</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s11897-013-0149-5</pub-id><pub-id pub-id-type="pmid">23868335</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>MD</given-names></name><name><surname>Eckman</surname><given-names>PM</given-names></name></person-group>
<article-title>Review of vasodilators in acute decompensated heart failure: the old and the new</article-title>. <source>J Card Fail</source> (<year>2013</year>) <volume>19</volume>:<fpage>478</fpage>&#x02013;<lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.cardfail.2013.05.007</pub-id><pub-id pub-id-type="pmid">23834924</pub-id></mixed-citation></ref></ref-list></back></article>